@article{6da21ecb845d4d76847b10f5e8d3b0d3,
title = "Brain PET and Cerebrovascular Disease",
keywords = "Artificial intelligence, Cerebrovascular disease, Cognitive impairment, PET",
author = "Katarina Chiam and Louis Lee and Kuo, \{Phillip H.\} and Gaudet, \{Vincent C.\} and Black, \{Sandra E.\} and Zukotynski, \{Katherine A.\}",
note = "Funding Information: P.H. Kuo is an employee of Invicro. He is a consultant and/or speaker for Amgen, Bayer, Chimerix, Eisai, Fusion Pharma, General Electric Healthcare, Invicro, Novartis, and UroToday. He is a recipient of research grants from Blue Earth Diagnostics and General Electric Healthcare. S. Black has received in-kind support from GE Healthcare and Lilly Avid, and has served as Advisor for Roche. K. Zukotynski has been a consultant for GE Healthcare and Invicro. V. Gaudet has received funding from Microsoft Canada and the Natural Sciences and Engineering Research Council of Canada.",
year = "2023",
month = jan,
doi = "10.1016/j.cpet.2022.09.007",
language = "English (US)",
volume = "18",
pages = "115--122",
journal = "PET Clinics",
issn = "1556-8598",
publisher = "W.B. Saunders",
number = "1",
}